Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-01-04 @ 1:39 PM
Study NCT ID:
NCT01605032
Status:
COMPLETED
Last Update Posted:
2020-08-20
First Post:
2012-03-07
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma
Sponsor:
Albert Einstein College of Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2018-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-03-07
First Submit QC Date:
None
Study First Post Date:
2012-05-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-03-17
Results First Submit QC Date:
None
Results First Post Date:
2020-08-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-11
Last Update Post Date:
2020-08-20
Last Update Post Date Type:
ACTUAL